Company intelligence / Profile preview

AB ANALITICA

Padua, Veneto, Italy

Ownership: Private
Employees: ~51
Development stage: Other

Overview

AB ANALITICA supplies CE-IVD certified molecular diagnostics, real-time PCR platforms, NGS kits, and specialized diagnostic tools for a broad range of infectious diseases, antibiotic resistance, genetics, and oncohematology, with more than 30 years of clinical deployment in Italy and over 30 countries abroad.

Therapeutic areas: ImmunologyInfectious DiseasesRare DiseasesHematologyOncologyWomen's Health
Modalities: In vitro diagnostic medical deviceMolecular biology reagentReal-Time PCR systemBreath test (Device)Next Generation Sequencing (NGS) kitSmall molecule (for breath test metabolites)
Industry: Molecular Diagnostics

Partnerships

Collaborations with Italian research centers and university hospitalsdistributorship agreements in >30 countries

Beyond the preview

Go deeper on AB ANALITICA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AB ANALITICA.

Explore the full profile